The current observation of the hyper-regulation of IL-10 gene among COVID-19 patients supported the finding that elevated levels of IL-10 in severe COVID-19 patients were initially ascribed to the negative feedback through its anti-inflammatory activities [56]. The gene discussed is IL10; the disease is COVID-19.